Whole genomic sequencing as a tool for diagnosis of drug and multidrug-resistance tuberculosis in an endemic region in Mexico.

<h4>Background</h4>Whole genome sequencing (WGS) has been proposed as a tool for diagnosing drug resistance in tuberculosis. However, reports of its effectiveness in endemic countries with important numbers of drug resistance are scarce. The goal of this study was to evaluate the effecti...

Full description

Bibliographic Details
Main Authors: Carlos Francisco Madrazo-Moya, Irving Cancino-Muñoz, Betzaida Cuevas-Córdoba, Vanessa González-Covarrubias, Martín Barbosa-Amezcua, Xavier Soberón, Raquel Muñiz-Salazar, Armando Martínez-Guarneros, Claudia Bäcker, José Zarrabal-Meza, Clara Sampieri-Ramirez, Antonio Enciso-Moreno, Michael Lauzardo, Iñaki Comas, Roberto Zenteno-Cuevas
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0213046
id doaj-b428412dd72d45ed84cfa36dc2cf9b2c
record_format Article
spelling doaj-b428412dd72d45ed84cfa36dc2cf9b2c2021-03-04T10:30:04ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-01146e021304610.1371/journal.pone.0213046Whole genomic sequencing as a tool for diagnosis of drug and multidrug-resistance tuberculosis in an endemic region in Mexico.Carlos Francisco Madrazo-MoyaIrving Cancino-MuñozBetzaida Cuevas-CórdobaVanessa González-CovarrubiasMartín Barbosa-AmezcuaXavier SoberónRaquel Muñiz-SalazarArmando Martínez-GuarnerosClaudia BäckerJosé Zarrabal-MezaClara Sampieri-RamirezAntonio Enciso-MorenoMichael LauzardoIñaki ComasRoberto Zenteno-Cuevas<h4>Background</h4>Whole genome sequencing (WGS) has been proposed as a tool for diagnosing drug resistance in tuberculosis. However, reports of its effectiveness in endemic countries with important numbers of drug resistance are scarce. The goal of this study was to evaluate the effectiveness of this procedure in isolates from a tuberculosis endemic region in Mexico.<h4>Methods</h4>WGS analysis was performed in 81 tuberculosis positive clinical isolates with a known phenotypic profile of resistance against first-line drugs (isoniazid, rifampin, ethambutol, pyrazinamide and streptomycin). Mutations related to drug resistance were identified for each isolate; drug resistant genotypes were predicted and compared with the phenotypic profile. Genotypes and transmission clusters based on genetic distances were also characterized.<h4>Findings</h4>Prediction by WGS analysis of resistance against isoniazid, rifampicin, ethambutol, pyrazinamide and streptomycin showed sensitivity values of 84%, 96%, 71%, 75% and 29%, while specificity values were 100%, 94%, 90%, 90% and 98%, respectively. Prediction of multidrug resistance showed a sensitivity of 89% and specificity of 97%. Moreover, WGS analysis revealed polymorphisms related to second-line drug resistance, enabling classification of eight and two clinical isolates as pre- and extreme drug-resistant cases, respectively. Lastly, four lineages were identified in the population (L1, L2, L3 and L4). The most frequent of these was L4, which included 90% (77) of the isolates. Six transmission clusters were identified; the most frequent was TC6, which included 13 isolates with a L4.1.1 and a predominantly multidrug-resistant condition.<h4>Conclusions</h4>The results illustrate the utility of WGS for establishing the potential for prediction of resistance against first and second line drugs in isolates of tuberculosis from the region. They also demonstrate the feasibility of this procedure for use as a tool to support the epidemiological surveillance of drug- and multidrug-resistant tuberculosis.https://doi.org/10.1371/journal.pone.0213046
collection DOAJ
language English
format Article
sources DOAJ
author Carlos Francisco Madrazo-Moya
Irving Cancino-Muñoz
Betzaida Cuevas-Córdoba
Vanessa González-Covarrubias
Martín Barbosa-Amezcua
Xavier Soberón
Raquel Muñiz-Salazar
Armando Martínez-Guarneros
Claudia Bäcker
José Zarrabal-Meza
Clara Sampieri-Ramirez
Antonio Enciso-Moreno
Michael Lauzardo
Iñaki Comas
Roberto Zenteno-Cuevas
spellingShingle Carlos Francisco Madrazo-Moya
Irving Cancino-Muñoz
Betzaida Cuevas-Córdoba
Vanessa González-Covarrubias
Martín Barbosa-Amezcua
Xavier Soberón
Raquel Muñiz-Salazar
Armando Martínez-Guarneros
Claudia Bäcker
José Zarrabal-Meza
Clara Sampieri-Ramirez
Antonio Enciso-Moreno
Michael Lauzardo
Iñaki Comas
Roberto Zenteno-Cuevas
Whole genomic sequencing as a tool for diagnosis of drug and multidrug-resistance tuberculosis in an endemic region in Mexico.
PLoS ONE
author_facet Carlos Francisco Madrazo-Moya
Irving Cancino-Muñoz
Betzaida Cuevas-Córdoba
Vanessa González-Covarrubias
Martín Barbosa-Amezcua
Xavier Soberón
Raquel Muñiz-Salazar
Armando Martínez-Guarneros
Claudia Bäcker
José Zarrabal-Meza
Clara Sampieri-Ramirez
Antonio Enciso-Moreno
Michael Lauzardo
Iñaki Comas
Roberto Zenteno-Cuevas
author_sort Carlos Francisco Madrazo-Moya
title Whole genomic sequencing as a tool for diagnosis of drug and multidrug-resistance tuberculosis in an endemic region in Mexico.
title_short Whole genomic sequencing as a tool for diagnosis of drug and multidrug-resistance tuberculosis in an endemic region in Mexico.
title_full Whole genomic sequencing as a tool for diagnosis of drug and multidrug-resistance tuberculosis in an endemic region in Mexico.
title_fullStr Whole genomic sequencing as a tool for diagnosis of drug and multidrug-resistance tuberculosis in an endemic region in Mexico.
title_full_unstemmed Whole genomic sequencing as a tool for diagnosis of drug and multidrug-resistance tuberculosis in an endemic region in Mexico.
title_sort whole genomic sequencing as a tool for diagnosis of drug and multidrug-resistance tuberculosis in an endemic region in mexico.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2019-01-01
description <h4>Background</h4>Whole genome sequencing (WGS) has been proposed as a tool for diagnosing drug resistance in tuberculosis. However, reports of its effectiveness in endemic countries with important numbers of drug resistance are scarce. The goal of this study was to evaluate the effectiveness of this procedure in isolates from a tuberculosis endemic region in Mexico.<h4>Methods</h4>WGS analysis was performed in 81 tuberculosis positive clinical isolates with a known phenotypic profile of resistance against first-line drugs (isoniazid, rifampin, ethambutol, pyrazinamide and streptomycin). Mutations related to drug resistance were identified for each isolate; drug resistant genotypes were predicted and compared with the phenotypic profile. Genotypes and transmission clusters based on genetic distances were also characterized.<h4>Findings</h4>Prediction by WGS analysis of resistance against isoniazid, rifampicin, ethambutol, pyrazinamide and streptomycin showed sensitivity values of 84%, 96%, 71%, 75% and 29%, while specificity values were 100%, 94%, 90%, 90% and 98%, respectively. Prediction of multidrug resistance showed a sensitivity of 89% and specificity of 97%. Moreover, WGS analysis revealed polymorphisms related to second-line drug resistance, enabling classification of eight and two clinical isolates as pre- and extreme drug-resistant cases, respectively. Lastly, four lineages were identified in the population (L1, L2, L3 and L4). The most frequent of these was L4, which included 90% (77) of the isolates. Six transmission clusters were identified; the most frequent was TC6, which included 13 isolates with a L4.1.1 and a predominantly multidrug-resistant condition.<h4>Conclusions</h4>The results illustrate the utility of WGS for establishing the potential for prediction of resistance against first and second line drugs in isolates of tuberculosis from the region. They also demonstrate the feasibility of this procedure for use as a tool to support the epidemiological surveillance of drug- and multidrug-resistant tuberculosis.
url https://doi.org/10.1371/journal.pone.0213046
work_keys_str_mv AT carlosfranciscomadrazomoya wholegenomicsequencingasatoolfordiagnosisofdrugandmultidrugresistancetuberculosisinanendemicregioninmexico
AT irvingcancinomunoz wholegenomicsequencingasatoolfordiagnosisofdrugandmultidrugresistancetuberculosisinanendemicregioninmexico
AT betzaidacuevascordoba wholegenomicsequencingasatoolfordiagnosisofdrugandmultidrugresistancetuberculosisinanendemicregioninmexico
AT vanessagonzalezcovarrubias wholegenomicsequencingasatoolfordiagnosisofdrugandmultidrugresistancetuberculosisinanendemicregioninmexico
AT martinbarbosaamezcua wholegenomicsequencingasatoolfordiagnosisofdrugandmultidrugresistancetuberculosisinanendemicregioninmexico
AT xaviersoberon wholegenomicsequencingasatoolfordiagnosisofdrugandmultidrugresistancetuberculosisinanendemicregioninmexico
AT raquelmunizsalazar wholegenomicsequencingasatoolfordiagnosisofdrugandmultidrugresistancetuberculosisinanendemicregioninmexico
AT armandomartinezguarneros wholegenomicsequencingasatoolfordiagnosisofdrugandmultidrugresistancetuberculosisinanendemicregioninmexico
AT claudiabacker wholegenomicsequencingasatoolfordiagnosisofdrugandmultidrugresistancetuberculosisinanendemicregioninmexico
AT josezarrabalmeza wholegenomicsequencingasatoolfordiagnosisofdrugandmultidrugresistancetuberculosisinanendemicregioninmexico
AT clarasampieriramirez wholegenomicsequencingasatoolfordiagnosisofdrugandmultidrugresistancetuberculosisinanendemicregioninmexico
AT antonioencisomoreno wholegenomicsequencingasatoolfordiagnosisofdrugandmultidrugresistancetuberculosisinanendemicregioninmexico
AT michaellauzardo wholegenomicsequencingasatoolfordiagnosisofdrugandmultidrugresistancetuberculosisinanendemicregioninmexico
AT inakicomas wholegenomicsequencingasatoolfordiagnosisofdrugandmultidrugresistancetuberculosisinanendemicregioninmexico
AT robertozentenocuevas wholegenomicsequencingasatoolfordiagnosisofdrugandmultidrugresistancetuberculosisinanendemicregioninmexico
_version_ 1714805747586433024